PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-15.68%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.11B
AUM Growth
+$1.11B
(-14%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
11.5%
Top 10 Holdings %
Top 10 Hldgs %
47.87%
Holding
199
New
48
Increased
49
Reduced
18
Closed
34
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$31.1M |
| 2 |
Humana
HUM
|
$20.1M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.6M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$13.9M |
| 5 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$12.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$68.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$11.8M |
| 3 |
Baxter International
BAX
|
$10.9M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$8.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$7.63M |
Sector Composition
| 1 | Healthcare | 92.2% |
| 2 | Consumer Discretionary | 0.11% |
| 3 | Industrials | 0.05% |
| 4 | Financials | 0.02% |
| 5 | Consumer Staples | 0.01% |
